1-6 of 6
H. Sindermann
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Klinisch-onkologische Forschung in Deutschland aus Sicht der pharmazeutischen Industrie

Available to Purchase
Subject Area:
Oncology
P. Hilgard, H. Sindermann
Journal: Onkologie
Onkologie (1997) 20 (5): 422–424.
https://doi.org/10.1159/000218996
Published Online: 21 October 2010
View articletitled, Klinisch-onkologische Forschung in Deutschland aus Sicht der pharmazeutischen Industrie
Open the PDF for Klinisch-onkologische Forschung in Deutschland aus Sicht der pharmazeutischen Industrie in another window
Journal Articles

Standard-Arbeitsanweisungen (Standard Operating Procedures, SOP) der Phase l/ll-Studiengruppe der Arbeitsgemeinschaft für Internistische Onkologie (AIO) in der Deutschen Krebsgesellschaft

Available to Purchase
Subject Area:
Oncology
W.E. Berdel, R. Becher, L. Edler, A.-R. Hanauske, S. Kerpel-Fronius, W. Rauschning, H.-J. Schmoll, H. Sindermann
Journal: Onkologie
Onkologie (1994) 17 (3): 311–338.
https://doi.org/10.1159/000218434
Published Online: 11 May 2009
View articletitled, Standard-Arbeitsanweisungen (Standard Operating Procedures, SOP) der Phase l/ll-Studiengruppe der Arbeitsgemeinschaft für Internistische Onkologie (AIO) in der Deutschen Krebsgesellschaft
Open the PDF for Standard-Arbeitsanweisungen (Standard Operating Procedures, SOP) der Phase l/ll-Studiengruppe der Arbeitsgemeinschaft für Internistische Onkologie (AIO) in der Deutschen Krebsgesellschaft in another window
Journal Articles

Miltefosine Solution: Prognostic Factors for the Outcome of Topical Treatment of Skin Meta-static Breast Cancer

Available to Purchase
Subject Area:
Oncology
H. Sindermann, K. Junge, K. Burk
Journal: Onkologie
Onkologie (1994) 17 (1): 21–26.
https://doi.org/10.1159/000218377
Published Online: 08 May 2009
View articletitled, Miltefosine Solution: Prognostic Factors for the Outcome of Topical Treatment of Skin Meta-static Breast Cancer
Open the PDF for Miltefosine Solution: Prognostic Factors for the Outcome of Topical Treatment of Skin Meta-static Breast Cancer in another window
Journal Articles

Phase II Trial of Orally Administered Miltefosine in Advanced Colorectal Cancer

Available to Purchase
Subject Area:
Oncology
R. Becher, K. Kloke, A. Füger, K. Bremer, A. Drozd, U.R. Kleeberg, D. Fritze, K. Rieche, H. Sindermann
Journal: Onkologie
Onkologie (1993) 16 (1): 11–15.
https://doi.org/10.1159/000218217
Published Online: 06 May 2009
View articletitled, Phase II Trial of Orally Administered Miltefosine in Advanced Colorectal Cancer
Open the PDF for Phase II Trial of Orally Administered Miltefosine in Advanced Colorectal Cancer in another window
Journal Articles

Phase I Study of Weekly Oral Miltefosine (Hexadecyl-Phosphocholine) in Cancer Patients

Available to Purchase
Subject Area:
Oncology
S. Danhauser-Riedl, A. Drozd, M. Zafferani, U. Bruntsch, M. Peukert, H. Sindermann, H.W. Präuer, J.R. Siewert
Journal: Onkologie
Onkologie (1991) 14 (5): 392–400.
https://doi.org/10.1159/000217014
Published Online: 28 April 2009
View articletitled, Phase I Study of Weekly Oral Miltefosine (Hexadecyl-Phosphocholine) in Cancer Patients
Open the PDF for Phase I Study of Weekly Oral Miltefosine (Hexadecyl-Phosphocholine) in Cancer Patients in another window
Journal Articles

Hexadecylphosphocholine (D 18506) in the Topical Treatment of Skin Metastases: A Phase-I Trial

Available to Purchase
Subject Area:
Oncology
C. Unger, H. Eibl, A. Breiser, H.W. von Heyden, J. Engel, P. Hilgard, H. Sindermann, M. Peukert, G.A. Nagel
Journal: Onkologie
Onkologie (1988) 11 (6): 295–296.
https://doi.org/10.1159/000216563
Published Online: 27 April 2009
View articletitled, Hexadecylphosphocholine (D 18506) in the Topical Treatment of Skin Metastases: A Phase-I Trial
Open the PDF for Hexadecylphosphocholine (D 18506) in the Topical Treatment of Skin Metastases: A Phase-I Trial in another window